We demonstrated the pattern in presentation of primary intracranial tumors in a population-based cohort of patients aged 0-24 years identified from the National Cancer Registry for England, using linked medical records from primary care and hospitals. We used generalized additive models to estimate temporal changes in presentation rates. Borderline and malignant tumors presented at a similar rate in primary care (6.4 and 6.6 consultations per 100 patients each month) and in hospital (3.4 and 3.6). Benign tumors presented earlier but less frequently (rate = 4.4 and rate ratio = 0.75, 95% CI = 0.60-0.93, in primary care; rate = 2.6 and rate ratio = 0.83, 95% CI = 0.77-0.89, in hospital). Many tumors began presenting shortly before their diagnosis, but less aggressive tumors were likely to present earlier in primary care. Earlier detection of less aggressive tumors in primary care may reduce the risk of complications and morbidity among survivors.
StillerC. Childhood Cancer in Britain: Incidence, Survival, Mortality. Oxford, UK: Oxford University Press; 2007.
2.
ChuTPShahAWalkerD. Pattern of symptoms and signs of primary intracranial tumours in children and young adults: a record linkage study. Arch Dis Child. 2015;100:1115–1122.
3.
HamiltonWKernickD. Clinical features of primary brain tumours: a case-control study using electronic primary care records. Br J Gen Pract. 2007;57:695–699.
4.
Dang-TanTFrancoEL. Diagnosis delays in childhood cancer: a review. Cancer. 2007;110:703–713.
5.
WilneSCollierJKennedyC. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol. 2007;8:685–695.
6.
ChuTPShahAWalkerD. Where are the opportunities for an earlier diagnosis of primary intracranial tumours in children and young adults?Eur J Paediatr Neurol. 2017;21:388–395.
7.
Dixon-WoodsMFindlayMYoungB. Parents’ accounts of obtaining a diagnosis of childhood cancer. Lancet. 2001;357:670–674.
8.
CrawfordJRSantiMRVezinaG. CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis. Neurology. 2007;68:1668–1673.
9.
DobrovoljacMHengartnerHBoltshauserE. Delay in the diagnosis of paediatric brain tumours. Eur J Pediatr. 2002;161:663–667.
10.
HalperinECFriedmanHS. Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis?Cancer. 1996;78:874–880.
11.
HalperinECWatsonDMGeorgeSL. Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer. 2001;91:1444–1450.
12.
KukalKDobrovoljacMBoltshauserE. Does diagnostic delay result in decreased survival in paediatric brain tumours?Eur J Pediatr. 2009;168:303–310.
ReuleckeBCErkerCGFiedlerBJ. Brain tumors in children: initial symptoms and their influence on the time span between symptom onset and diagnosis. J Child Neurol. 2008;23:178–183.
15.
Office for National Statistics. Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2006, England. Newport, UK: Office for National Statistics; 2008.
16.
Steliarova-FoucherEStillerCLacourB. International Classification of Childhood Cancer, third edition. Cancer. 2005;103:1457–1467.
17.
World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Geneva, Switzerland: World Health Organization; 1977.
18.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems. Geneva, Switzerland: World Health Organization; 1992.
19.
KleihuesPLouisDNScheithauerBW. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–225; discussion 226-219.
20.
LouisDNOhgakiHWiestlerOD. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.
21.
FritzAGPercyCLJackA. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization, 2000. Available fromhttp://codes.iarc.fr (accessed 3 Jan 2018).
22.
FritzAGPercyCLJackA. International Classification of Diseases for Oncology. 1st revision of 3rd ed. Geneva, Switzerland: World Health Organization, 2013. Available fromhttp://codes.iarc.fr (accessed 3 Jan 2018).
23.
LouisDOhgakiHWiestlerO. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: International Agency for Research on Cancer; 2007.
24.
ColemanMPBabbPDamieckiP. Cancer Survival Trends in England and Wales, 1971-1995: Deprivation and NHS Region. London, UK: The Stationery Office; 1999.
25.
HerrettEGallagherAMBhaskaranK. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44:827–836.
26.
HerrettEThomasSLSchoonenWM. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69:4–14.
27.
HanchettN. ONS to HES Linkage Release 1: Core Documentation. London, UK: Thames Cancer Registry, King’s College London; 2008.
28.
Thames Cancer Registry. National Cancer Data Repository—1990 to 2008: Matching Registry Records to Hospital Episodes Version 1.2. London, UK: Thames Cancer Registry, King’s College London; 2011.
29.
International Agency for Research on Cancer and International Association of Cancer Registries. Cancer Registration: Principles and Methods. Lyon, France: International Agency for Research on Cancer; 1991.
30.
United Kingdom Association of Cancer Registries. Po/99/03 Definition of Diagnosis Date. United Kingdom Association of Cancer Registries, 2011.
31.
AnsellPJohnstonTSimpsonJ. Brain tumor signs and symptoms: analysis of primary health care records from the UKCCS. Pediatrics. 2010;125:112–119.
32.
ChambersJHastieT. Statistical Models in S. London, UK: Chapman & Hall; 1993.
33.
ClevelandWS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74:829–836.
34.
ClevelandWSDevlinSJ. Locally weighted regression: an approach to regression-analysis by local fitting. J Am Stat Assoc. 1988;83:596–610.
R Core Team. R: a language and environment for statistical computing. http://www.R-project.org/. Published 2011.
37.
DommettRMRedanielMTStevensMC. Features of childhood cancer in primary care: a population-based nested case-control study. Br J Cancer. 2012;106:982–987.
38.
DommettRMRedanielMTStevensMC. Features of cancer in teenagers and young adults in primary care: a population-based nested case-control study. Br J Cancer. 2013;108:2329–2333.
39.
HamiltonWHajioffSGrahamJ. Suspected cancer (part 1—children and young adults): visual overview of updated NICE guidance. BMJ. 2015;350:h3036.
40.
BrasmeJFChalumeauMDozF. Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study. Eur J Pediatr. 2012;171:25–32.
41.
BrasmeJFGrillJGasparN. Evidence of increasing mortality with longer time to diagnosis of cancer: is there a paediatric exception?Eur J Cancer. 2014;50:864–866.
42.
MehtaVChapmanAMcNeelyPD. Latency between symptom onset and diagnosis of pediatric brain tumors: an Eastern Canadian geographic study. Neurosurgery. 2002;51:365–372; discussion 372-373.
43.
FellegiIPSunterAB. A theory for record linkage. J Am Stat Assoc. 1969;64:1183–1210.
44.
GillL. Methods for Automatic Record Matching and Linkage and Their Use in National Statistics. Norwich, UK: Her Majesty’s Stationery Office, 2001.
45.
Statistics New Zealand. Data Integration Manual. Wellington, New Zealand: Statistics New Zealand; 2006.
46.
LaunayEMorfouaceMDeneux-TharauxC. Quality of reporting of studies evaluating time to diagnosis: a systematic review in paediatrics. Arch Dis Child. 2014;99:244–250.
47.
WellerDVedstedPRubinG. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106:1262–1267.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
